John, Kovach

A phase 1 study of a novel inhibitor of protein phosphatase 2A alone and with docetaxel.

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: TPS2636-TPS2636

10.1200/jco.2014.32.15_suppl.tps2636